InvestWiser

Ortoma AB Series B

ORT-BNasdaq StockholmHealthcareMarket value 456 m SEK
10.10SEK −1.0%
last day · Price as of 18 November 2026

The answer first

Does Ortoma beat the market?

No, Ortoma has not beaten the market over the last year.

Ortoma−26.3%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 33% of Nordic stocks

    • Quality53
    • Value8
    • Trend67

    No. 97 of 195 in healthcare

Max for seven days

Follow Ortoma with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Ortoma

From today, at a price of 10.10 SEK. Write why you follow Ortoma, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Ortoma

Your first answer is free, no account needed.

Do you own Ortoma, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Ortoma and a few more. Free, no card.

Past year against the exchange and Super Stock
Ortoma−26.3%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Ortoma has fallen 26.3% over the past year, including dividends.
  • Overall, Ortoma ranks better than 33% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 84.6%. The price is 87.3% below its peak now.

What do analysts think of Ortoma?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

33

Quality, value and trend together. Better than 33% of Nordic stocks.

No. 97 of 195 in healthcare

Quality53
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 123 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity–
  • Asset turnoverSales divided by everything the company owns0.17
  • Return on equityProfit divided by equity−37.9%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value8
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 146 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity2.6
  • P/SPrice divided by sales13.5
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend67
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 57 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+29.5%
  • 6 months+18.7%
  • 9 months−22.0%
  • 12 months−26.3%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+41.3%
3 years, per year
+10.2%
5 years, per year
−18.1%
10 years, per year
−12.6%
Largest fall, 3 years
−84.6%
From a peak to the bottom
From the peak now
−87.3%
How far the price is from the peak
Volatility, 1 year
91.1%
How much the price swings over a year
Beta, 1 year
0.98
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Ortoma

One fund we follow owns Ortoma. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About Ortoma

Ortoma AB Series B is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 14 employees.

Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position. The company was founded in 2001 and is based in Gothenburg, Sweden.

See the full analysis of Ortoma.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market